PFM Health Sciences’s Terns Pharmaceuticals TERN Stock Holding History

PFM Health Sciences’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-172,962	Closed	-$9.12M	–	110
2026 Q1	$9.12M	Buy	+172,962	New	+$7.1M	0.83%	40
2021 Q2	–	Sell	-329,274	Closed	-$7.24M	–	97
2021 Q1	$7.24M	Buy	+329,274	New	+$7.22M	0.22%	74

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

PFM Health Sciences's TERN Position: Q2 2026 in Review

PFM Health Sciences sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 172,962 shares — an estimated $9.12M sold.

PFM Health Sciences first reported a position in TERN in Q1 2021 and held it in 2 quarters. The position peaked at $9.12M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

PFM Health Sciences reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
PFM Health Sciences sold 172,962 Terns Pharmaceuticals shares in Q2 2026, an estimated $9.12M.
PFM Health Sciences first reported a position in Terns Pharmaceuticals in Q1 2021 and held it in 2 quarters.
PFM Health Sciences's Terns Pharmaceuticals position peaked at $9.12M in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on PFM Health Sciences's 13F filing for Q2 2026, filed 14 Aug 2026.